FOR IMMEDIATE RELEASE
The DUST Test and Mosaic Diagnostics Announce Strategic Partnership to Advance Environmental and Clinical Correlation for Mold-Related Illness
New collaboration bridges the gap between home environmental assessment and clinical testing, empowering consumers with more actionable insights into the connection between home and health
CLEARWATER, Fla. – (July 14, 2026) – The DUST Test and Mosaic Diagnostics have announced a strategic partnership designed to strengthen the connection between environmental exposures and health outcomes. By combining advanced home-based environmental screening with high-quality, precision laboratory testing, the collaboration provides both consumers and practitioners with a more comprehensive framework for understanding how mold exposure and water-damaged buildings may be impacting wellness and long-term health.
The partnership represents a significant step forward in addressing one of the most persistent challenges in environmental medicine: understanding the relationship between what is present within a home environment and what is occurring within the body. For consumers, this means a clearer, more complete picture, without needing to navigate separate environmental and clinical tests on their own.
As part of this collaboration, The DUST Test is introducing the Mycotoxin Body + Home Panel, a new bundled offering that pairs The DUST Test’s at-home dust screening with Mosaic Diagnostics’ MycoTOX Profile®, an at-home urine-based assay that evaluates mycotoxins from some of the most toxigenic mold classes. Together, the two tests give consumers and practitioners a side-by-side view of mold species present in the home alongside any related mycotoxin levels in the body, all from the comfort of home.
“Historically, environmental testing and patient testing have often existed in separate silos,” said Michael Rubino, Co-Founder of The DUST Test and Founder of HomeCleanse. “This partnership helps bridge that gap by giving both consumers and practitioners a clearer picture of how environmental findings may correlate with clinical biomarkers. Our goal is to provide more confidence, clarity, and direction, whether someone is proactively investing in their wellness and longevity or working with a clinical provider to get to the root of ongoing symptoms.”
Mosaic Diagnostics brings more than three decades of experience in functional laboratory testing, including advanced mycotoxin analysis that helps evaluate a person’s internal exposure and toxic burden. Together, the two organizations are creating an integrated approach that allows consumers and practitioners to assess both potential sources of exposure and the impact those exposures may be having on the body.
